Nothing Special   »   [go: up one dir, main page]

FR2819255B1 - Derives chimiques et leur application comme agent antitelomerase - Google Patents

Derives chimiques et leur application comme agent antitelomerase

Info

Publication number
FR2819255B1
FR2819255B1 FR0100205A FR0100205A FR2819255B1 FR 2819255 B1 FR2819255 B1 FR 2819255B1 FR 0100205 A FR0100205 A FR 0100205A FR 0100205 A FR0100205 A FR 0100205A FR 2819255 B1 FR2819255 B1 FR 2819255B1
Authority
FR
France
Prior art keywords
application
chemical derivatives
antitelomerase
agent
antitelomerase agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0100205A
Other languages
English (en)
Other versions
FR2819255A1 (fr
Inventor
Patrick Mailliet
Jean Francois Riou
Marcel Alasia
Thomas Caulfield
Gilles Doerflinger
Odile Petitgenet
Emmanuelle Renou
Jean Louis Mergny
Abdelazize Laoui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0100205A priority Critical patent/FR2819255B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to IL15679402A priority patent/IL156794A0/xx
Priority to AU2002229859A priority patent/AU2002229859B2/en
Priority to US10/040,370 priority patent/US6858608B2/en
Priority to JP2002556184A priority patent/JP2004520350A/ja
Priority to MXPA03005975A priority patent/MXPA03005975A/es
Priority to PCT/FR2002/000057 priority patent/WO2002055515A1/fr
Priority to EP02710956A priority patent/EP1351957A1/fr
Priority to CA002433723A priority patent/CA2433723A1/fr
Publication of FR2819255A1 publication Critical patent/FR2819255A1/fr
Application granted granted Critical
Publication of FR2819255B1 publication Critical patent/FR2819255B1/fr
Priority to US10/954,808 priority patent/US7179816B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR0100205A 2001-01-09 2001-01-09 Derives chimiques et leur application comme agent antitelomerase Expired - Fee Related FR2819255B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR0100205A FR2819255B1 (fr) 2001-01-09 2001-01-09 Derives chimiques et leur application comme agent antitelomerase
CA002433723A CA2433723A1 (fr) 2001-01-09 2002-01-09 Derives chimiques et leur application comme agent antitelomerase
US10/040,370 US6858608B2 (en) 2001-01-09 2002-01-09 Chemical derivatives and their application as antitelomerase agents
JP2002556184A JP2004520350A (ja) 2001-01-09 2002-01-09 化学誘導体と抗テロメラーゼ剤としてのその用途
MXPA03005975A MXPA03005975A (es) 2001-01-09 2002-01-09 Derivados quimicos y su aplicacion como agente antitelomerasa.
PCT/FR2002/000057 WO2002055515A1 (fr) 2001-01-09 2002-01-09 Derives chimiques et leur application comme agent antitelomerase
IL15679402A IL156794A0 (en) 2001-01-09 2002-01-09 Chemical derivatives and their use as anti-telomerase agent
AU2002229859A AU2002229859B2 (en) 2001-01-09 2002-01-09 Chemical derivatives and their use as anti-telomerase agent
EP02710956A EP1351957A1 (fr) 2001-01-09 2002-01-09 Derives chimiques et leur application comme agent antitelomerase
US10/954,808 US7179816B2 (en) 2001-01-09 2004-09-30 Chemical derivatives and their application as antitelomerase agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0100205A FR2819255B1 (fr) 2001-01-09 2001-01-09 Derives chimiques et leur application comme agent antitelomerase

Publications (2)

Publication Number Publication Date
FR2819255A1 FR2819255A1 (fr) 2002-07-12
FR2819255B1 true FR2819255B1 (fr) 2003-02-28

Family

ID=8858610

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0100205A Expired - Fee Related FR2819255B1 (fr) 2001-01-09 2001-01-09 Derives chimiques et leur application comme agent antitelomerase

Country Status (8)

Country Link
EP (1) EP1351957A1 (fr)
JP (1) JP2004520350A (fr)
AU (1) AU2002229859B2 (fr)
CA (1) CA2433723A1 (fr)
FR (1) FR2819255B1 (fr)
IL (1) IL156794A0 (fr)
MX (1) MXPA03005975A (fr)
WO (1) WO2002055515A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887873B2 (en) 2001-03-23 2005-05-03 Aventis Pharma S.A. Triazine derivatives and their application as antitelomerase agents
US7173032B2 (en) * 2001-09-21 2007-02-06 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
FR2850970B1 (fr) * 2003-02-07 2006-07-07 Aventis Pharma Sa Derives chimiques se liant de maniere tres specifique aux structures d'adn en g-quadruplexe et leur application comme agent anticancereux specifique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206768D0 (en) * 1992-03-27 1992-05-13 Jarman Michael New compounds for use in the treatment of cancer
US5767278A (en) * 1995-10-06 1998-06-16 Geron Corporation Telomerase inhibitors
JPH1160573A (ja) * 1997-08-22 1999-03-02 Nippon Kayaku Co Ltd トリアジン誘導体及びテロメラーゼ阻害剤

Also Published As

Publication number Publication date
EP1351957A1 (fr) 2003-10-15
MXPA03005975A (es) 2005-02-14
FR2819255A1 (fr) 2002-07-12
IL156794A0 (en) 2004-02-08
AU2002229859B2 (en) 2008-03-13
WO2002055515A1 (fr) 2002-07-18
CA2433723A1 (fr) 2002-07-18
JP2004520350A (ja) 2004-07-08

Similar Documents

Publication Publication Date Title
FR20C1039I2 (fr) Derives de l'uk-2a
DE60207627D1 (de) Überzug und Überzugszusammensetzung
DE60215046D1 (de) Vernebler und anwendungsverfahren
IS6858A (is) Trísólpýridín sem bólgueyðandi efni
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
MA27001A1 (fr) Derives spirotricycliques nouveaux et leur utilisation comme inhibiteurs de phospho-diesterase-7
DE60204857D1 (de) Flüssigkeitszerstäuber
NO20034490D0 (no) Fremgangsmåte for sammensetting av absorberende gjenstand til personlig stell
ATE555761T1 (de) Absorbierender artikel
DE60209850D1 (de) Absorbierender Artikel
DE60214783D1 (de) Absorbierender Gegenstand
FR2830516B1 (fr) Suspension de turboreacteur
BR0201972B1 (pt) montante de suspensão.
DE60225452D1 (de) Wiederverschliessbarer absorbierender artikel
PT1250321E (pt) Composicao de gliburida
ITMI20021834A1 (it) Sospensione di apparecchiature
DE60208700D1 (de) Schälgerät und zugehörige verfahren
FI20011300A (fi) Sprinkleri
NO20041968L (no) Anvendelse av cystationin
BR0209263B1 (pt) composições de revestimento compreendendo produtos de carbono de área t alta
FI20010075A (fi) Terveysvaikutteinen tuote ja menetelmä
NO20035605D0 (no) Pediatrisk formulering av gatifloxacin
LU90483B1 (fr) Compositions nouvelles de m-thanesulfonate de parox-tine
FR2819255B1 (fr) Derives chimiques et leur application comme agent antitelomerase
DE60225446D1 (de) Flammgeschützte zusammensetzung und artikel

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091030